Vandana Singh
·
January 2, 2025
Benzinga
Merck's Winrevair (sotatercept) gains UK approval for PAH treatment. Key trial results highlight significant exercise capacity improvements.
read more
April 26, 2025
March 1, 2025
Bloomberg
April 8, 2025
March 12, 2025